Home > Back to Publisher > Report Information

The Global Market for Pain Management Drugs and Devices

BCC Research
August 1, 2009
213 Pages - SKU: WA2418706

Abstract Table of Contents Related Reports

Countries covered: Global

REPORT HIGHLIGHTS

The global market for pain management pharmaceuticals and devices amounted to $19.1 billion in 2008 and is expected to increase to $32.8 billion in 2013. The compound annual growth rate (CAGR) for the 5-year period is projected at 11.5%.
The pharmaceuticals segment dominated the market at $17.6 billion in 2008. That figure is expected to increase to $30.2 billion in 2013, for a CAGR of 11.5%.
The devices segment of the market generated $1.48 billion in sales in 2008 and is projected to increase to $2.5 billion in 2013, for a CAGR of 11.4%.

CHAPTER ONE: INTRODUCTION: STUDY GOALS AND OBJECTIVES; REASONS FOR DOING THE STUDY; SCOPE OF REPORT; METHODOLOGY; ANALYST CREDENTIALS; RELATED BCC STUDIES; BCC RESEARCH ONLINE SERVICES; DISCLAIMER
CHAPTER TWO: SUMMARY
CHAPTER THREE: INDUSTRY OVERVIEW: HISTORY OF PAIN AND PAIN TREATMENT; THE PERCEPTION OF PAIN; Types of Pain; Acute Pain; Chronic Pain; ASSESSMENT OF PAIN; Subjective; Objective; HOW PAIN IS DIAGNOSED; THERMOGRAPHY; HOW PAIN IS TREATED; THE AGING U.S. POPULATION; WORLD DEMOGRAPHICS; LIFE EXPECTANCY FOR MEN AND WOMEN; INCIDENCE OF PAIN; PREVALENCE OF PAIN; Severe Headache or Migraine, Low Back, and Neck Pain; Joint Pain; Cancer Pain; Pain Management in Cancer; Description of Some of Key Medications for Cancer Pain Control; HIV/AIDS Related Pain; Burn Pain; Burn Classifications; Stages of Burn Healing; Challenges Associated with Burn Pain; Burn Pain Management; Dental Pain; Treatment for Dental Pain; GENDER AND PAIN; OTHER INFLUENCES DETERMINING HOW PAIN IS FELT AMONG INDIVIDUALS; Objective Pain Measurement; OBSTETRICS PAIN; ORTHOPEDIC PAIN; PEDIATRIC PAIN; SURGICAL PAIN; GLOBAL PAIN MANAGEMENT
CHAPTER FOUR: INDUSTRY TRENDS: OVERVIEW; UNDERTREATMENT ISSUES; TREATMENT OF PAIN AND ISSUES FACING THE PROFESSIONAL SEGMENT; MANAGED CARE PAIN MANAGEMENT ISSUES; PRODUCT PIPELINE; NEW DEVELOPMENTS IN BREAKTHROUGH CANCER PAIN; OPIOID-INDUCED CONSTIPATION AND REDUCED COMPLIANCE; PATENT EXPIRATION; GENERIC PARTICIPATION; NEW FDA APPROVAL REQUIREMENTS FOR PAIN THERAPIES; FUTURE OF PAIN RESEARCH; OF PAIN RESEARCH (CONTINUED); PATIENT OUTCOMES RESEARCH; DRUG DELIVERY SYSTEMS; Oral and Extended Release; Topical and Transdermal; Intravenous; Patient-Controlled Analgesia; Iontophoresis; TABLE 22 ADVANTAGES OF IONTOPHORETIC DRUG DELIVERY; Electromechanical Transport
CHAPTER FIVE: TREATING PAIN: PHARMACEUTICAL PAIN MANAGEMENT; PRESCRIPTION PAIN MANAGEMENT PRODUCTS; Analgesic Drugs; Non-Narcotic; Narcotic; Full and Partial Agonists; Agonist-Antagonists; Nonsteroid Anti-inflammatory Drugs; Anti-migraine Drugs; Antidepressant, Anticonvulsants, and Other Pain Relieving Drugs; ANESTHETICS; General; Topical; OVER-THE-COUNTER PAIN MANAGEMENT PRODUCTS; ANALGESIC DRUGS; NONSTEROID ANTI-INFLAMMATORY DRUGS; Aspirin Products and Aspirin Combination Products; Ibuprofen and Ibuprofen Combination Products; Ketoprofen Products; Naproxen Compounds; ANTI-MIGRAINE DRUGS; TOPICAL ANESTHETIC DRUGS; PAIN MANAGEMENT DEVICES; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATORS; PAIN TEM; SPINAL CORD STIMULATORS; NEUROMUSCULAR STIMULATORS; OTHER PAIN MANAGEMENT DEVICES; PAIN MANAGEMENT PROCEDURES; ALTERNATIVE METHODS OF PAIN MANAGEMENT; Psychological Therapies; Biofeedback; Hypnosis; Behavior Modification/Operant Conditioning; Relaxation and Stress Management Training; Imagery; Autogenic Training; Psychosocial Interventions; Distraction and Reframing; Ice 116; Warm Bath; Massage; Joint Mobilization; Manipulation; Traction; Acupuncture/Acupressure; Laser Therapy; Surgery; Radiation Therapy; Radio Frequency Neuroablation, Epiduroscopy; PAIN MANAGEMENT SERVICES; HOME CARE; HOSPICE; NATIONAL HOSPICE ORGANIZATION; HOSPITALS; PAIN CLINICS; SKILLED NURSING FACILITIES
CHAPTER SIX: PRESCRIPTION PAIN MANAGEMENT MARKET SIZE AND ANALYSIS: TOTAL MARKET; PRESCRIPTION PAIN MARKETS BY PRODUCT TYPE; MARKET PARTICIPANTS; FUTURE MARKET ANALYSIS
CHAPTER SEVEN: PAIN MANAGEMENT DEVICE MARKET SIZE AND ANALYSIS: TOTAL PAIN MANAGEMENT DEVICE MARKET; PAIN MARKETS BY PRODUCT TYPE; MARKET PARTICIPANTS; FUTURE MARKET ANALYSIS
CHAPTER EIGHT: TOTAL MARKET SUMMARY: TOTAL PAIN MANAGEMENT MARKET; MARKET PERCENTAGE BY PRODUCT TYPE
CHAPTER NINE: COMPANY PROFILES: PHARMACEUTICAL PAIN MANAGEMENT MANUFACTURERS; ABBOTT LABORATORIES; ASTRAZENECA; BARR LABORATORIES, INC; BAXTER INTERNATIONAL; BRISTOL-MYERS SQUIBB CO; ELI LILLY & CO; GLAXOSMITHKLINE; MEDTRONIC, INC.; MERCK & CO., INC; ORTHO-MCNEIL PHARMACEUTICALS; PFIZER; WYETH
APPENDIX I: SELECTED PAIN MANAGEMENT CLINICS BY STATE: PAIN CLINICS; PAIN SOCIETIES AND ASSOCIATIONS; INTERNATIONAL ASSOCIATIONS AND ORGANIZATIONS
APPENDIX II: COMPANY NAMES AND ADDRESSES: PAIN MANAGEMENT PHARMACEUTICAL MANUFACTURERS
LIST OF TABLES: SUMMARY TABLE WORLDWIDE PAIN MANAGEMENT; PHARMACEUTICALS AND DEVICES MARKET AT; MANUFACTURERS’ SALES LEVELS, THROUGH 2013 ($ MILLIONS); TABLE 1 OBJECTIVE SIGNS OF PAIN; TABLE 2 U.S. POPULATION ESTIMATES BY AGE GROUP AND; GENDER, 1950 AND 2000 (MILLIONS); TABLE 3 U.S. POPULATION PROJECTIONS BY AGE GROUP AND; GENDER FOR SPECIFIC YEARS, 2010-2050 (MILLIONS); TABLE 4 WORLD POPULATION GROWTH BY GEOGRAPHICAL; REGION, 2008 AND 2013 (MILLIONS); TABLE 5 ESTIMATED AND PROJECTED WORLD POPULATION BY; AGE AND GENDER, 2008 AND 2013 (MILLIONS); TABLE 6 CURRENT AND PROJECTED U.S. LIFE EXPECTANCY AT; BIRTH BY GENDER AND YEAR, 2000-2020 (YEARS); TABLE 7 SEVERE HEADACHE OR MIGRAINE, LOW BACK PAIN, AND; NECK PAIN AMONG ADULTS, 18 YEARS OF AGE AND OVER*, 1997-; 2009 (%); TABLE 8 JOINT PAIN AMONG ADULTS 18 YEARS OF AGE AND OVER*,; 2002-2009 (%); TABLE 9 CANCER PAIN MEDICATION; TABLE 10 ESTIMATED HIV REPORTED CASES BY SELECTED; CHARACTERISTICS, 2007; TABLE 11 BURN CLASSIFICATIONS; TABLE 12 PAIN BY SELECTED CATEGORY AND GENDER IN THE 18+; U.S. POPULATION*, 1997-2006 (%); TABLE 13 NUMBER OF PHYSICIAN GRADUATES FROM 1990-2006; (THOUSANDS); TABLE 14 NUMBER OF PHYSICIANS PER 100,000 RESIDENT; POPULATION, 2006; TABLE 15 TOTAL NUMBER OF ABUSE TREATMENT FACILITIES AND; CLIENTS, 2000-2007; TABLE 16 BENEFITS OF PRESCRIPTION MONITORING PROGRAMS; FOR MEDICAL BOARDS; TABLE 17 STATES WITH ELECTRONIC PRESCRIPTION MONITORING; PROGRAMS; TABLE 18 STATE CONTROLLED SUBSTANCES SCHEDULING; AUTHORITIES AND OTHER CONTACT INFORMATION; TABLE 19 PAIN-MANAGEMENT DRUG PRODUCT PIPELINES; TABLE 20 U.S. PATENT EXPIRATION DATES FOR SELECT PAIN; DRUGS; TABLE 21 FIRST TIME PRESCRIPTION GENERIC PAIN MANAGEMENT; AND APPROVALS, JANUARY 2004-APRIL 2009; TABLE 22 ADVANTAGES OF IONTOPHORETIC DRUG DELIVERY; TABLE 23 RECENT APPLICATIONS/APPROVALS, THROUGH 3/2009; TABLE 24 MOST COMMONLY USED GENERAL ANESTHETIC AGENTS; TABLE 25 ACETAMINOPHEN AND ACETAMINOPHEN COMBINATION; PRODUCTS; TABLE 26 ASPIRIN AND ASPIRIN COMBINATION PRODUCTS; TABLE 27 IBUPROFEN AND IBUPROFEN COMBINATION PRODUCTS; TABLE 28 KETOPROFEN PRODUCTS; TABLE 29 OTC NONSTEROID ANTI-INFLAMMATORIES; TABLE 30 ANTI-MIGRAINE PRODUCTS; TABLE 31 TOPICAL ANESTHETIC PRODUCTS; TABLE 32 NHO COMMITTEES; TABLE 33 WORLDWIDE PRESCRIPTION PAIN MANAGEMENT; PHARMACEUTICALS MARKET, THROUGH 2013 ($ MILLIONS); TABLE 34 GLOBAL PRESCRIPTION NARCOTIC AND NSAIDS; MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($; MILLIONS); TABLE 35 GLOBAL PRESCRIPTION ANTI-MIGRAINE DRUG; MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($; MILLIONS); TABLE 36 GLOBAL PRESCRIPTION ANESTHESIA MANUFACTURER; MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS); TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET AT; MANUFACTURERS’ SALES LEVELS BY PRODUCT TYPE, THROUGH; 2013 ($ MILLIONS); TABLE 38 GLOBAL NEUROMUSCULAR STIMULATOR/TENS; MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($; MILLIONS); TABLE 39 GLOBAL SPINAL CORD STIMULATOR MANUFACTURER; MARKET SHARE BY MANUFACTURER, 2008 ($ MILLIONS); TABLE 40 GLOBAL PAIN MANAGEMENT PHARMACEUTICALS AND; DEVICES MARKET BY CATEGORY, THROUGH 2013 ($ MILLIONS); TABLE 41 PERCENT DISTRIBUTION OF THE WORLDWIDE PAIN; MANAGEMENT MARKET BY SEGMENT, 2008 (%, $ MILLIONS); TABLE 42 ALABAMA CLINICS; TABLE 43 CALIFORNIA PAIN CLINICS; TABLE 44 COLORADO PAIN CLINICS; TABLE 45 DELAWARE PAIN CLINICS; TABLE 46 FLORIDA PAIN CLINICS; TABLE 47 HAWAII PAIN CLINICS; TABLE 48 IOWA PAIN CLINICS; TABLE 49 MAINE PAIN CLINICS; TABLE 50 NEVADA PAIN CLINICS; TABLE 51 OREGON PAIN CLINICS; TABLE 52 PENNSYLVANIA PAIN CLINICS; TABLE 53 RHODE ISLAND PAIN CLINICS; TABLE 54 SOUTH DAKOTA PAIN CLINICS; TABLE 55 TEXAS PAIN CLINICS; TABLE 56 WASHINGTON PAIN CLINICS
LIST OF FIGURES: SUMMARY FIGURE WORLDWIDE PAIN MANAGEMENT; PHARMACEUTICALS AND DEVICES MARKET AT; MANUFACTURERS’ SALES LEVELS, 2006-2013 ($ MILLIONS); FIGURE 1 PAIN-MANAGEMENT TECHNIQUES; FIGURE 2 U.S. POPULATION ESTIMATES, BY AGE GROUP, 1950 AND; 2000 (MILLIONS); FIGURE 3 U.S. POPULATION ESTIMATES BY GENDER, 1950 AND 2000; (MILLIONS); FIGURE 4 U.S. POPULATION PROJECTIONS, BY SELECTED AGE; GROUP FOR SPECIFIC YEARS, 2010-2050 (MILLIONS); FIGURE 5 U.S. POPULATION PROJECTIONS, BY GENDER FOR; SPECIFIC YEARS, 2010-2050 (MILLIONS); FIGURE 6 WORLD POPULATION BY GEOGRAPHICAL REGION, 2008; AND 2013 (MILLIONS); FIGURE 7 ESTIMATED AND PROJECTED WORLD POPULATION BY; AGE AND GENDER, 2008 AND 2013 (MILLIONS); FIGURE 8 CURRENT AND PROJECTED U.S. LIFE EXPECTANCY AT; BIRTH BY GENDER AND YEAR, 2000-2020 (YEARS); FIGURE 9 SEVERE HEADACHE OR MIGRAINE, LOW BACK PAIN, AND; NECK PAIN AMONG ADULTS, 18 YEARS OF AGE AND OVER*, 1997-; 2009 (%); FIGURE 10 JOINT PAIN AMONG ADULTS 18 YEARS OF AGE AND; OVER*, 2002-2009 (%); FIGURE 11 CAUSES OF CANCER PAIN; FIGURE 12 ESTIMATED HIV REPORTED CASES BY AGE GROUP, 2007; FIGURE 13 ESTIMATED HIV REPORTED CASES BY GENDER, 2007; FIGURE 14 ESTIMATED HIV REPORTED CASES BY RACE, 2007; FIGURE 15 BURN PAIN MANAGEMENT APPROACH; FIGURE 16 PAIN BY SELECTED CATEGORY AND GENDER IN THE 18+; U.S. POPULATION*, 1997 AND 2006 (%); FIGURE 17 TOTAL NUMBER OF ABUSE TREATMENT FACILITIES,; 2000-2007; FIGURE 18 TOTAL NUMBER OF ABUSE TREATMENT CLIENTS, 2000-; 2007; FIGURE 19 TOTAL NUMBER OF STATES WITH ELECTRONIC; PRESCRIPTION MONITORING PROGRAMS BY YEAR OF; ENACTMENT; FIGURE 20 WORLDWIDE PRESCRIPTION PAIN MANAGEMENT; PHARMACEUTICALS MARKET, 2006-2013 ($ MILLIONS); FIGURE 21 GLOBAL PRESCRIPTION NARCOTIC AND NSAIDS; MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 ($; MILLIONS); FIGURE 22 GLOBAL PRESCRIPTION ANTI-MIGRAINE DRUG; MANUFACTURER MARKET SHARE BY REVENUE, 2008 (%); FIGURE 23 GLOBAL PRESCRIPTION ANESTHESIA MANUFACTURER; MARKET SHARE BY MANUFACTURER, 2008 (%); FIGURE 24 GLOBAL PAIN MANAGEMENT DEVICES MARKET BY; PRODUCT TYPE, THROUGH 2013 ($ MILLIONS); FIGURE 25 GLOBAL NEUROMUSCULAR STIMULATOR/TENS UNIT; MANUFACTURER MARKET SHARE BY MANUFACTURER, 2008 (%); FIGURE 26 GLOBAL SPINAL CORD STIMULATOR MANUFACTURER; MARKET SHARE, 2008 (%); FIGURE 27 GLOBAL PAIN MANAGEMENT PHARMACEUTICALS AND; DEVICES MARKET BY CATEGORY, 2006-2013 ($ MILLIONS); FIGURE 28 PERCENT DISTRIBUTION OF THE WORLDWIDE PAIN; MANAGEMENT MARKET BY SEGMENT, 2008 (%)

More Global Drug Delivery Reports

Global Inhaled Antibiotics Market 2011-2015 by Infiniti Research Limited
TechNavio’s analysts forecast the Global Inhaled Antibiotics market to reach US$875 million by 2015. One of the key factors contributing to this market growth is ...

Drug Delivery: Surveying the Global Competitive Landscape by Espicom Healthcare Intelligence
This report provides key insights for you to... Identify exciting development companies with novel drug delivery technologies Find out more about the ...

Nanotechnology for Drug Delivery: Global Market for Nanocarriers by Cientifica Ltd.
Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 ...

Nanotechnology in Medical Applications: The Global Market by BCC Research
INTRODUCTION STUDY GOALS AND OBJECTIVES The aim of this report is to provide detailed market, technology and industry analyses to help readers quantify and qualify ...

Nanotechnology in Drug Delivery: Global Markets by Cientifica Ltd.
Cientifica's latest report, Nanotechnology in Drug Delivery: Global Markets, indicates nanotech-enabled drug delivery therapeutics is set to grow from a current value of $2.3 billion ...

See all reports like this >>

The Global Market for Pain Management Drugs and Devices

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service